🇺🇸 FDA
Patent

US 6500859

Method for treating atherosclerosis or restenosis using microtubule stabilizing agent

expired A61KA61K31/335A61K31/337

Quick answer

US patent 6500859 (Method for treating atherosclerosis or restenosis using microtubule stabilizing agent) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/335, A61K31/337, A61K9/0024, A61P